Remove Article Remove Documentation Remove Packaging
article thumbnail

How ready are you? Preparing for the impact of EU GMP Annex 1 on primary packaging

European Pharmaceutical Review

Indeed, a key aspect of EU GMP Annex 1 is the requirement for pharmaceutical manufacturers to develop a comprehensive Contamination Control Strategy (CCS) that documents their approach to assuring the sterile drug product’s high quality and, therefore, enhancing patient safety. Register your details to read more The post How ready are you?

article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

This article explores just one aspect of the RMP, that of RMMs, and how their effectiveness is measured with Dr Sophie Jouaville, an associate principal at IQVIA working on the design and oversight of non-interventional real-world evidence (RWE) safety and health economics and outcomes research (HEOR) studies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

These standardised documents provide meticulously curated and scientifically approved information. 11 This requirement directly contradicts what is included in Article 63. 11 This requirement directly contradicts what is included in Article 63. Article 63 EMA (29 January 2020).

article thumbnail

Pre-Filled Syringes East Coast 2022

pharmaphorum

Primary Packaging material designers. Secondary packagers. POST CONFERENCE WORKSHOP A: EU MDR 2017/745 Article 117 Requirements. Overview of the workshop: The workshop is aimed to provide an introduction to the key elements of the Medical Device Regulation that Companies affected by article 117 need to consider.

article thumbnail

Methodology to Define a Pharma 4.0™ Roadmap

ISPE

The key to data integrity compliance is a well-functioning data governance system 1 , 2 in which the data flow path for all business processes and equipment—such as in manufacturing, laboratory, and clinical studies—is fully understood and documented by a detailed process data flow map. It supports the analysis of Industry 4.0 to Industry 4.0

article thumbnail

DSCSA Compliance for Independent Pharmacies

DiversifyRx

If you think that doesn’t happen nowadays, here’s an article about recent counterfeit HIV medications. This tracking involves the use of unique product identifiers, such as serial numbers and barcodes, on drug packaging to track their movement. It also enables precise tracking and tracing of each drug package.

article thumbnail

DSCSA Postponement And What It Means For Independent Pharmacies

DiversifyRx

Small Dispensers and the 6/12/2024 FDA Announcement Concerning DSCSA This week’s article on the recent DSCSA postponement comes from PRS Pharmacy Services. The original article can be found HERE. The DSCSA Adventure continues. Identifiers All products received must contain a product identifier.